Better understanding of bone growth and regeneration mechanisms within periosteal tissues will improve understanding of bone physiology and pathology. Macrophage contributions to bone biology and repair have been established but specific investigation of periosteal macrophages has not been undertaken. We used an immunohistochemistry approach to characterize macrophages in growing murine bone and within activated periosteum induced in a mouse model of bone injury. Osteal tissue macrophages (osteomacs) and resident macrophages were distributed throughout resting periosteum. In tissues collected from 4-week-old mice, osteomacs were observed intimately associated with sites of periosteal diaphyseal and metaphyseal bone dynamics associated with normal growth. This included F4/80 + Mac-2 − /low osteomac association with extended tracks of bone formation (modeling) on diphyseal periosteal surfaces. Although this recapitulated endosteal osteomac characteristics, there was subtle variance in the morphology and spatial organization of periosteal modeling-associated osteomacs, which likely reflects the greater structural complexity of periosteum. Osteomacs, resident macrophages and inflammatory macrophages (F4/80 + Mac-2 hi ) were associated with the complex bone dynamics occurring within the periosteum at the metaphyseal corticalization zone. These three macrophage subsets were also present within activated native periosteum after bone injury across a 9-day time course that spanned the inflammatory through remodeling bone healing phases. This included osteomac association with foci of endochondral ossification within the activated native periosteum. These observations confirm that osteomacs are key components of both osteal tissues, in spite of salient differences between endosteal and periosteal structure and that multiple macrophage subsets are involved in periosteal bone dynamics.
Better understanding of bone growth and regeneration mechanisms within periosteal tissues will improve understanding of bone physiology and pathology. Macrophage contributions to bone biology and repair have been established but specific investigation of periosteal macrophages has not been undertaken. We used an immunohistochemistry approach to characterize macrophages in growing murine bone and within activated periosteum induced in a mouse model of bone injury. Osteal tissue macrophages (osteomacs) and resident macrophages were distributed throughout resting periosteum. In tissues collected from 4-week-old mice, osteomacs were observed intimately associated with sites of periosteal diaphyseal and metaphyseal bone dynamics associated with normal growth. This included F4/80 + Mac-2 − /low osteomac association with extended tracks of bone formation (modeling) on diphyseal periosteal surfaces. Although this recapitulated endosteal osteomac characteristics, there was subtle variance in the morphology and spatial organization of periosteal modeling-associated osteomacs, which likely reflects the greater structural complexity of periosteum. Osteomacs, resident macrophages and inflammatory macrophages (F4/80 + Mac-2 hi ) were associated with the complex bone dynamics occurring within the periosteum at the metaphyseal corticalization zone. These three macrophage subsets were also present within activated native periosteum after bone injury across a 9-day time course that spanned the inflammatory through remodeling bone healing phases. This included osteomac association with foci of endochondral ossification within the activated native periosteum. These observations confirm that osteomacs are key components of both osteal tissues, in spite of salient differences between endosteal and periosteal structure and that multiple macrophage subsets are involved in periosteal bone dynamics. Macrophages have broad functional potential as a consequence of their heterogeneity, microenvironmental awareness and plasticity. To harness the potential of macrophage biology for improving human health, more refined characterization of macrophage subsets in any given biological response is needed. We previously characterized the resident macrophages within bone, osteal tissue macrophages (osteomacs) with minimum identification criteria being F4/80 + Mac-2 − /low cells within three cell diameters of a bone surface. 1,2 Osteomacs 1-8 and/or recruited inflammatory macrophages 4, 5, [9] [10] [11] [12] [13] can influence bone dynamic events, particularly bone-forming osteoblast anabolic outcomes. Macrophages have also been shown to be associated with sites of pathological bone loss, including prosthetic joint loosening, 14 and have been implicated in systemic bone loss in an animal model of osteoporosis. 15 Better appreciation of the full breadth of macrophage subtypes associated with bone dynamics and their bone-specific functional potential is required. Here we focused on macrophage contributions to skeletal biology and repair specifically in the periosteum.
The periosteum is a specialized connective tissue composed of a vascularized and innervated fibrous membrane that encapsulates bone. It has two layers: an outer fibrous capsule layer containing elastic connective tissue (including Sharpey's fibres), fibroblasts and blood vessels; and, an inner cambium layer containing capillaries, nerves, pre-osteoblasts/bone lining cells, osteoblasts and undifferentiated mesenchymal stromal/stem cells (also referred to as periosteumderived progenitor cells). 16, 17 Periosteal bone modeling is essential for long bone formation 17, 18 and also in bone accrual induced by mechanical loading. 18, 19 In contrast, the resting endosteum is a singlecell layer of predominantly mesenchymal cells (osteoprogenitors, committed bone lining cells and mature osteoblasts) lining the internal surface of bone and is in direct contact with adjacent bone marrow and sinusoidal network. 20 Endosteal composition and biology have been more thoroughly investigated compared with periosteum. These tissues can respond independently and often differently to the same stimuli (review in ref. 18 ). Progenitor cells within the endosteum and periosteum have different potential: endosteal progenitors are restricted to osteoblastic differentiation but periosteal progenitors have osteoblastic and chondrocytic bi-potential. 21 Therefore, although many physiological bone dynamic processes occur in both endosteum and periosteum, they are distinct environments with varying biological mechanisms and outcomes.
We have reported that both resting endosteum and periosteum contain osteomacs. 1 We have provided detailed in situ characterization of osteomacs in both resting and active endosteal surfaces and provided insight into their bone-specific functions. 1,2,22, 23 We have not reported detailed characterization of periosteal osteomacs. Given the clear variance in tissue structure, cell constituency and osteochondroprogenitor cell characteristics, 18 it is important to independently characterize periosteal osteomacs and their distribution.
The regenerative potential of periosteum is well described 16, 17, 21, 24 and this has been taken advantage of in many orthopaedic procedures (review in ref. 16 ). Given it is the major source of osteochondroprogenitor cells during fracture repair, 21, 25 the regenerative potential of periosteum has been primarily assigned to these resident mesenchymal progenitor cells, with little consideration of the potential involvement of macrophages in this process. 26, 27 During normal fracture healing chondrogenesis and subsequently soft callus formation initiates within de novo granulation tissue that originates from the hematoma. 4, 28 The osteochondrogenic progenitors that are recruited to the hematomaderived granulation tissue are likely sourced from the adjacent periosteum, which undergoes a proliferative response to the injury, and bone marrow. 28 If formation of a hematoma is disrupted/delayed, successful bone repair still proceeds, but the anabolic response instead initiates within the fracture adjacent native periosteum. 28 Therefore, understanding cellular mechanisms within native periosteum, as well as the de novo granulation tissue, will be important for understanding bone repair and likely be more relevant in stress/hairline fracture, 19, 29 periostitis and/or stabilized non-displaced simple fractures that often fail to cause hematoma formation. Anabolic initiation within the native periosteum may also participate in low-energy fragility fracture healing. 30 In this study, we characterized periosteal osteomacs and investigated the distribution of inflammatory versus resident macrophages, including osteomacs, within both naive and inflamed periosteum using an established model of cortical bone healing (tibial injury model). 31 The specific advantages of the tibial injury model are that it is minimally invasive (periosteum, endosteum and bone marrow left predominantly intact), 3, 31, 32 and therefore periosteal granulation tissue formation does not predominate the repair mechanism.
RESULTS

Periosteum in actively growing mice contains both osteomacs and resident macrophages
The distribution of long bone periosteal macrophages was examined in naive, actively growing 4-week-old C57Bl/6 mice, with anti-F4/80 and anti-Mac-2 IHC performed in serial sections. The F4/80 antigen is a robust pan-macrophage marker in mouse tissues that is not expressed by osteoclasts. 33, 34 Mac-2 expression is indicative of activated/inflammatory macrophages, 35 but it is also expressed in osteoclasts 36 and chondrocytes. 37 Osteomacs were identified using our previously designated criteria: F4/80 + Mac-2 − /low cells within three cells diameter of a bone surface. 1, 38 A comprehensive description of mouse long bones together with anatomical localization of different regions is presented in Supplementary Figure 1 .
In actively growing bone, periosteal accrual on cortical diaphyseal bone surfaces occurs via bone modeling. This was easily identified in the actively growing 4-week-old bone using the mature osteoblast marker osteocalcin (Figure 1a) . In a near-serial section stained for F4/80 expression, numerous ramified osteomacs were observed intercalated within the mature osteoblasts (Figure 1b, arrows) . This integrated patchwork pattern varied from osteomac distribution at sites of endosteal bone modeling where they have a more elongated morphology and form a relatively continuous canopy structure. 1 These modeling site-associated periosteal osteomacs were F4/80 + Mac-2 − /low (Figures 1c and d) , recapitulating their endosteal counterparts. 1 Periosteal osteomac/macrophage frequency was reduced in skeletally mature bone (10-week-old), particularly in the diaphyseal region (data not shown), which occurred in conjunction with previously reported age-associated periosteal atrophy. 30 F4/80 + macrophages were also intercalated within metaphyseal periosteum, which is considerably thicker than diaphyseal periosteum particularly in actively growing bone. 30 The metaphyseal corticalization zone during bone growth is a highly dynamic site with bone catabolism, modeling and remodeling occurring simultaneously in a focused anatomical location. Within the periosteum adjacent to the corticalization zone, F4/80 + macrophages were present in both the cambium and fibrous capsule layers (Figures 1e and g ). Large ramified F4/80 + Mac-2 − /low macrophages meeting the anatomical osteomac criteria were present in the cambium tissue close to the bone surface (Figures 1g and h, boxes) . In addition to these bonafide osteomacs, two distinct resident macrophage populations were also identified. It is assumed that these inflammatory macrophages have been activated as a consequence of aseptic mechanisms associated with bone growth, including upregulation of 'pro-inflammatory' cytokines such as tumor necrosis factor. 39 Expression of Ly6C, an antigen associated with recruited inflammatory monocytes, 40 was also examined in the naive periosteum of 4-week-old mice and the vast majority of osteomacs/macrophages within periosteum did not express this marker (data not shown). Therefore, metaphyseal periosteum contains both definitive osteomacs and at least two other resident macrophage populations.
Periosteal macrophage frequency was determined using flow cytometry assessment of periosteal single-cell preparations that were isolated using a rapid enzyme-free method to avoid enzyme-mediated antigen shedding. Successful isolation of periosteal cells was confirmed by 20-fold enrichment of CD45 − CD31 − CD51 + osteoblast in endosteal preparations compared with bone marrow from contralateral limbs (Po0.002, not shown). The percent frequency of F4/80 + Ly6G − macrophages was similar in periosteum (average 14%) and bone marrow (average 17%) preparations (Figure 2f ), which is similar to the 16% macrophage frequency previously demonstrated in neonatal calvarial cell preparations. 1 Based on immunohistology examination above, osteomacs represent the largest portion of macrophages in the periosteal cell preparation.
Osteomacs, resident and inflammatory macrophages are present in inflamed periosteal tissue during the anabolic phase of bone healing in vivo The distribution of macrophages, including osteomacs, within the periosteum during a bone healing time course in a tibial injury model was investigated. 3, 31 This fully stabilized bone injury heals predominantly via intramembranous ossification forming an intra-medullar and inter-cortical bone bridge. It proceeds through standard repair stages of inflammation phase (days 1-3), anabolic modeling phase (days 4-7) and a catabolic modeling/remodeling phase (days 8-12). It also induces a conservative periosteal anabolic reaction associated with the injury site, but does not proceed to periosteal bridging by a callus. The advantage of this model is that it only causes focal damage to the periosteum, providing an opportunity to examine repair responses within the existing periosteum, which was identified by the presence of an intact fibrous capsule layer and clear presence of periosteal cambium layer.
During the early stages of anabolic repair 5 days post surgery, gross morphological assessment showed granulation tissue had formed immediately above the injury site and was continuous with tissue meeting the description of native periosteum (Figure 3a, boxed area) . The granulation tissue-inflamed periosteum transition occurred on average 500 μm from either side of the cortical edge of the bone injury site. The injury-associated inflamed diaphyseal periosteum was expanded ( Figure 3 ) compared with resting periosteum (Figure 1c and ref. 41 ). This expansion was due to both inflammatory cell infiltration and an increase in fibroblast and stromal-like cells (Figure 3 ). The inflamed periosteum contained three morphologically distinct strata: a cambium layer directly adjacent to bone surface; a superficial capsule layer; and an inflammatory layer, situated between the cambium and the capsule (Figures 3b-f) . Numerous F4/80 + cells were distributed throughout all three periosteal layers (Figures 3a and b) , and many of the F4/80 + cells within the cambium were osteomacs (F4/80 + Mac-2 − /low ; Figures 3b and c, arrows) . The cambium also contained a small population of F4/80 + Mac-2 high inflammatory macrophages (Figures 3b and c, boxed area) . Few, if any of the F4/80 + osteomacs/macrophages within the cambium expressed Ly6C (Figure 3d ). The cambium robustly stained for type 1 collagen (Col1a1) with the majority of cells and extracellular matrix within this layer positively stained (Figure 3e) . Expression of Col1a1 clearly demarked the cambium from the other layers (Figures 3b-f ) and suggests that this layer is directly participating in the fibrous repair process.
The inflammatory layer of the expanded periosteum integrated directly with granulation tissue and contained F4/80 + Mac-2 high inflammatory macrophages (Figures 3b and c, circled area) . These inflammatory macrophages were absent from the capsule (Figures 3b  and c, grey arrows) . The inflamed periosteum capsule macrophages were predominantly F4/80 + Mac-2 − /low Ly6C + (Figures 3b,c and d, grey  arrows) . A subset of macrophages with the same marker profile was also observed in the inflammatory layer (Figures 3b,c and d) . The majority of cells within the capsule layer were Ly6C + (Figure 2d ), including intercalated macrophages (Figures 3b-d , grey arrows), which was not observed in resting periosteum (data not shown). Overall, both osteomacs and inflammatory macrophages were prominent cellular components of the periosteal repair response in the early anabolic phase.
During late-stage anabolic repair 7 days post injury, the periosteal tissue associated with the injury zone remained expanded ( Figure 4 ) compared with naïve diaphyseal periosteum (Figure 1 ). Numerous F4/80 + macrophages were present throughout the inflamed periosteum ( Figure 3a , boxed area). Toluidine blue staining confirmed lack of proteoglycan-rich cartilage and, accordingly, absence of endochondral callus formation (Figure 4b ). Unlike day 5 post injury, the discrete inflammatory strata had resolved, leaving the two physiologic periosteal layers, which continued to be considerably thicker (Figure 3 ) than naive periosteum (Figure 1 ). F4/80 + Mac-2 − /low osteomacs were located within the periosteal cambium layer and did not express Ly6C (Figures 4c,d and e, black arrows). There were a smaller number of F4/80 + Mac-2 +/high inflammatory macrophages present within the periosteal cambium (Figures 4c and d, boxed area) . F4/80 + Mac-2 +/high inflammatory macrophages were also within the sub-capsular area of the fibrous capsule (Figures 4c and d, circled area) . Small numbers of F4/80 + Mac-2 − /low Ly6C + macrophages were still present in the superficial capsule (Figures 4c,d and e, grey arrows), although much lower levels of Ly6C antigen were expressed compared with day 5 (Figure 3 ). Col1a1 deposition was present throughout most of the periosteum at this time point, although there was a clear gradient with higher expression closer to the cortical bone surface (Figure 4f ). Interestingly at day 5 post surgery, the capsule layer was negative for Col1a1 expression (Figure 3e ). Col1a1 expression in the capsule layer coincided with appearance of F4/80 + Mac2 − /low Ly6C neg resident macrophages within the capsule (Figure 4 ).
Periosteal endochondral ossification was a late event occurring at the juncture of the wound induced granulation tissue and expanded endogenous periosteum At 9 days post surgery, the remodeling phase of injury repair had initiated as evidenced by early stage excavation of the intramedullary bone bridge (Figure 5a and Alexander et al. 3 ). In many samples characteristics of the injury-associated periosteum recapitulated those reported above for 7 days post surgery (Figure 4) . Although, toluidine blue staining combined with morphological features confirmed the presence of proteoglycan-rich soft callus (Figure 5b, asterisk) . Various stages of de novo bone formation were associated with the cartilage foci (Figures 5b and c, asterisk) , from Col1a1 dense proteoglycan-rich immature bone matrix (Figures 5b and c, circled areas) grey arrows) , but the capsule layer contained minimal to no Mac-2 staining (c). The cambium layer was Col1a1 + matrix enriched (e) with most cells in this layer expressing Col1a1 + . Specificity of staining confirmed using both RatIgG2b (f) and rabbit IgG matched isotype control (data not shown). Original magnification: a x4 and b-f x20.
( Figures 5d and e, black arrows) . However, many of the F4/80 + cells in close proximity to these new bone surfaces co-expressed Mac-2 (Figures 5c-e, boxed area) , and therefore it is unclear if they are osteomacs (osteomacs are Mac-2 − under physiologic conditions) that have become 'activated' or if they are inflammatory macrophages.
F4/80 + Mac-2 +/high inflammatory macrophages (Figures 5d and e, circled area) were also present within the cambium layer but predominantly restricted to Col1a1 low regions (Figures 5c-e) . F4/80 + Mac-2 − /low Ly6C + macrophages (Figures 5d,e and f, grey arrows) were present in the capsule region (Figures 5d,e and f, grey arrows) . Ly6C can also be expressed by endothelial cells 42 and Ly6C + cells were observed to be associated with a blood vessel bordering the cambium and capsule strata (Figure 5f ). Overall, multiple macrophage subsets are associated with anabolic foci within activated periosteum induced by bone injury. 
DISCUSSION
A comprehensive characterization of periosteal cellular composition is needed to improve knowledge of growth-associated, adaptive and pathological bone dynamics as well as bone repair/regeneration. 18 Herein we definitively demonstrate that osteomacs and resident macrophages are distributed throughout resting periosteum. Osteomacs also intimately associate with sites of periosteal diaphyseal and metaphyseal bone modeling during normal growth. Periosteal osteomacs had a similar expression profile to endosteal osteomacs (F4/80 + Mac-2 − /low Ly6C +/ − ), 1,23 however, their morphology and spatial organization varied subtly, which likely reflects the greater structural complexity of periosteum compared with endosteum. These observations confirm that osteomacs are key components of both osteal tissues, in spite of salient differences between endosteal and periosteal structure and adjacent environments. We also demonstrated that osteomacs (F4/80 + Mac-2 − /low Ly6C +/ − cell within three cell diameters of bone surface), resident macrophages (F4/80 + Mac-2 − /lowLy6C +/ − cell greater than three cell diameters of bone surface) and inflammatory macrophages (F4/80 + Mac-2 hi ) were prominent cells within activated native periosteum after bone injury across a 9-day time course that spanned the inflammatory through remodeling healing phases. This included osteomac association with foci of endochondral ossification within the activated native periosteum.
Interestingly, osteomacs/resident macrophages were the prominent, but not exclusive, macrophage subtype in areas of high Col1a1 deposition in activated native periosteum induced by bone injury. Macrophage induction of collagen deposition, particularly during wound healing and fibrotic responses, is well documented. 43 Inflammatory macrophages potentially directly influence collagen deposition via expression of Mac-2 and, as Mac-2 can be secreted, their location within the immediate site of collagen deposition is not required. 44 The distribution of Col1a1 staining within the cambium even raised the possibility that osteomacs and inflammatory macrophages within this tissue were actually expressing Col1a1, which was somewhat surprising but not unprecedented. 45, 46 Therefore, one of the functional contributions of osteomacs and other macrophage subsets within periosteum is likely stimulation of collagen deposition by mesenchymal cells, independent of whether they are osteoblasts or fibroblasts.
The presence of multiple macrophage subsets within activated native periosteum induced by bone injury provides further weight to the necessity of more clear distinction between the independent functional roles of distinct macrophages subsets during bone growth and repair/regeneration. Macrophage functional transition has been suggested to be a key mechanism orchestrating appropriate progression through the multiple phases of repair in soft tissue wound healing. 43 We would predict that macrophage contributions would be even more intricate during the greater biological complexity involved in bone regeneration/healing. This is also supported by our description of resident and inflammatory macrophage site and phase-specific distribution within granulation tissue during both intramembranous 3 or endochondral-mediated bone repair. 4 The dynamic growth events at the metaphyseal corticalization zone also exhibited complexity in periosteal macrophage diversity during normal growth. This suggests that the highly specialized developmental events occurring within this dynamic site, which involves both bone formation and resorption acting in concert, requires diverse functional support from multiple specialized macrophage subsets.
Broad spectrum macrophage depletion resulted in rapid and striking loss of endosteal osteoblast surface and osteoblast-mediated bone formation 1,2,5,6 and resulted in failed bone healing. 3, 4 Effort now needs to be focused on utilizing/developing more refined macrophage subset targeting approaches, so a clear map of specific macrophage subset contributions can be generated. Interestingly, in the tibial injury model, exogenous CSF-1 induced selective expansion of osteomacs within the intra-medullar woven bone bridge and subsequently enhanced Col1a1 deposition at this site. 3 This provides evidence that even a broad spectrum pro-macrophage molecule can achieve subsetspecific outcomes and consequently have targeted and positive impact on bone repair.
A clear outcome of the current study is that osteomacs/macrophages are located at sites of periosteal anabolism, and therefore it is likely that they contribute to the regenerative properties of periosteum. This needs to be confirmed by further investigation. Macrophage contributions to this regenerative potential have been considered for bone tissue engineering approaches. 26, 27 However, given the pleiotropic nature of macrophages, achieving appropriate and consistent promotion of macrophage trophic support of mesenchymal stem and progenitor cells, pro-angiogenic, chemotactic and regenerative cytokine/growth factor production versus inducing destructive/ foreign body macrophage reactions may prove therapeutically challenging. 26, 27 Achieving the appropriate macrophage functional balance will be aided by fine mapping of macrophage subset-specific contributions to periosteal anabolic and catabolic events and dissection of the molecules coordinating these outcomes. Our study also supports the previous suggestion 28 that anabolic events can initiate in the activated native periosteum adjacent to a fracture site. This suggests that fracture adjacent periosteum is a viable target organ for reigniting failed fracture repair and that promoting osteomacs/ macrophages may be integral to achieving this approach.
This study confirms that osteomac/macrophage participation during bone homeostasis and anabolism, independent of the anabolic mechanism, are likely consistent in all osteal tissues. As we have also previously reported osteomac presence in calvarial osteal tissue, 1 and others have shown macrophage contributions to calvarial injury repair, this cellular mechanism applies to both flat and long bones. Our evidence that osteomacs are present in human osteal tissues 1, 47 provides support that this biology is not a species-specific phenomenon. Definitive dissection of the specific roles of macrophages and osteoblasts in bone formation and repair was recently revealed to be more challenging than traditionally appreciated as macrophage can be resistant to lethal doses of irradiation. 48 Therefore, chimeric models are unlikely to conclusively distinguish macrophage versus mesenchymal contributions to bone biology or repair. Careful validation of osteoblast-restricted promoter expression models is also required as our current and previous 44, 45 data suggest that macrophages can express Col1a1. 45, 46 Overall the impact of osteomac/macrophage contributions needs to be carefully and appropriately considered during investigations of bone biology and bone repair.
METHODS Animals
Animal experiments were undertaken as dictated by the Australian code for the care and use of animals for scientific purposes. The University of Queensland Molecular Biosciences and/or Health Sciences Ethics Committees approved all protocols involving animals. C57Bl/6 male mice were supplied from Australian Resource Centre (Canning Vale, WA, Australia) and MacGreen mice (express green fluorescent protein transgene under the control of the cfms promoter resulting in expression in mature myeloid lineage cells, including macrophages 49 ) were sourced from an in-house breeding colony. Sample size was dictated by previous published data, 1,3,4 investigating macrophage contributions to bone biology and ethical considerations. No animals or samples were excluded from this study and were randomly allocated to different harvest points.
Periosteal cell enrichment and quantification of osteomac frequency
Femora were harvested from 4-week-old mixed gender MacGreen mice. Muscles surrounding the femora were removed by cutting the connective tissue from their attachment sites without scraping or damaging the periosteum. Epiphyseal bone ends were removed and central marrow was thoroughly flushed with 2% FBS/PBS using a 27G needle. Femora were cut in half longitudinally and the endosteal surface was gently flushed using a 19G needle and 2% FBS/PBS to dislodge any remaining endosteum and marrow. A periosteal-enriched single-cell suspension was generated using a gentle MACS Dissociator (Miltenyl Biotec, Macquarie Park, NSW, Australia) as per the manufacturer's instructions. Cells were washed and resuspended in 2% FBS/ PBS to generate a single-cell suspension. Bone marrow was flushed from contralateral limbs using a 2% FBS/PBS and a 27G needle.
Bone marrow from the contralateral femur and periosteal cell preparation was blocked with 2% FCS/PBS. 1 × 10 6 bone marrow cells were incubated with myeloid or mesenchymal antibody cocktails for 40 min in ice on a rotary shaker. Myeloid antibody cocktail included anti-F4/80-Alexa647 (AbD Serotec, Kidlington, UK) and anti-Ly6G-PE/Cy7 (Biolegend, San Diego, CA, USA). Mesenchymal antibody cocktail contained anti-Ter119-biotin (Biolegend), anti-CD31-BV605 (Biolegend), CD45-APC/Cy7 (Biolegend) and anti-CD51-PE (Biolegend). Specificity of staining was determined by comparison with unstained cells and appropriate isotype control cocktails. Cells were then washed and resuspended in 2% FCS/PBS. 5 μg/ml 7-amino actinomycin D (Life technologies, CA, USA) was added 10 min before flow cytometry analysis to allow exclusion of dead cells. Analysis was performed on Beckman Coulter's CyAn™ ADP Analyser (Beckman Coulter, Brea, CA, USA). A total of 300 000-1 000 000 events were collected and analysis performed on aggregate excluded, live cells using FlowJo software version 8.8.7 (Tree Star Data Analysis Software, Ashland, OR, USA). Macrophages were gated as F4/80 + Ly6G − cells (not shown). After exclusion of Ter119 + erythroid cells, osteoblasts were gated as CD45 − CD31 − CD51 + cells.
Immunofluorescence staining of naive bone tissue
Dual immunofluorescence staining was performed on deparaffinized and re-hydrated sections from 4-week-old C57Bl/6 mice (n = 7) using sequential staining with the following reagents: F4/80 (rat anti-mouse, Abcam, Cambridge, UK), goat anti-rat IgG F(ab') 2 -biotin (Santa Cruz Biotechnology, CA, USA), streptavidin conjugated-AlexaFluor647 (Thermo Fisher Scientific, Waltham, MA, USA), Mac2 (rat anti-mouse) directly conjugated to AlexaFluor488 (Biolegend). Nuclei were counterstained with DAPI (4′,6-diamidino-2-phenylindole dihydrochloride, Sigma-Aldrich, St Louis, MO, USA) and sections mounted with ProLong Gold mounting medium (Thermo Fisher Scientific). Slides were visualized using a Vectra-3 6-slide automated quantitative pathology imaging system (Perkin Elmer, Waltham, MA, USA) and spectral unmixing performed using inForm software v2.2 (Perkin Elmer).
Statistical analysis
Data is represented as mean ± s.d. an unpaired Student's t-test was used to analysis flow cytometry data using PRISM 5 (Graph pad software) and a P value of o0.05 was considered statistically significant.
Tibial bone injury model
11-12-week-old male C57Bl/6 mice were used in the cortical tibial injury model 31 and surgery was performed as previously described. 31 Tissue collection, processing and sectioning All left hind limbs were collected and processed as previously described 3 from either naive 4-or 10-week-old mice or mice subjected to tibial injury.
Immunohistochemistry and histology
Immunohistochemistry (IHC) was performed on deparaffinized and rehydrated sections at 3 sectional depths as previously described 1 with specific primary antibodies: F4/80 (rat anti-mouse, AbD Serotec), collagen type 1 (Col1a1; rabbit anti-mouse, US Biological, Swampscott, MA, USA), osteocalcin (rabbit anti-mouse, Alexix Biochemicals, San Diego, CA, USA), Mac-2 (rat anti-mouse, eBioscience, San Diego, CA, USA) and Ly6C (rat anti-mouse, Abcam); or relevant isotype control antibodies (normal ratIgG2b (AbD Serotec), rat IgG2a (BD Bioscience Pharmingen, San Jose, CA, USA) and normal rabbit IgG (Santa Cruz Biotechnology). All sections were counterstained using Mayer's hematoxylin (Sigma-Aldrich) and mounted using permanent mounting media (Thermo Fisher Scientific). Toluidine blue staining was carried out as previously described. 4 Tissue staining was viewed using a Nikon eclipse 80i microscope with a Nikon D5-Ri1 camera and NIS-elements imaging software version 3.1 (Nikon, Tokyo, Japan) or an Olympus BX50 microscope with an attached DP26 camera and imaged using Olympus CellSens standard 1.7 imaging software (Olympus, Tokyo, Japan).
